Literature DB >> 16394256

An interspecific functional complementation test in Drosophila for introductory genetics laboratory courses.

Lidon Monferrer1, Ruben Artero.   

Abstract

Introductory genetics courses often include evolutionary genetics concepts such as sequence homology and functional conservation. It is usually assumed that two sequences showing homology (i.e., sharing a common ancestral sequence) perform the same molecular function. The correlation, however, does not always hold true, and evidence for functional conservation must come from functional studies. In this study we describe a genetics laboratory class that demonstrates functional conservation between the Drosophila protein Muscleblind (Mbl) and its human ortholog MBNL1. We use the Gal4/UAS system to express MBNL1 in a Drosophila mutant background and measure the in vivo activity of the human protein by rescue of mbl mutant phenotype in embryos. As a control, ubiquitous expression of Drosophila MblC, one of the four protein isoforms encoded by the gene, increased by 71% the viability of mbl mutant embryos and greatly reduced the hypercontracted abdomen of mutant larvae. In a parallel experiment, human MBNL1 provided a robust rescue of the embryonic lethality (78%) and improved abdomen hypercontraction as well. Under both conditions, rescued larvae die as first instars, probably due to overexpression effects, lack of alternative protein isoforms, or incomplete expression in critical tissues such as the nervous system. The use of two constructs in the rescue experiment (UAS-mblC and UAS-MBNL1) and the incomplete rescue prompt several questions for students. The fact that a human protein works in a Drosophila cellular context illustrates the use of an in vivo test to prove functional conservation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394256     DOI: 10.1093/jhered/esj003

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  9 in total

1.  A putative amino acid transporter of the solute carrier 6 family is upregulated by lithium and is required for resistance to lithium toxicity in Drosophila.

Authors:  J Kasuya; G A Kaas; T Kitamoto
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

2.  RNA binding specificity of Drosophila muscleblind.

Authors:  Emily S Goers; Rodger B Voelker; Devika P Gates; J Andrew Berglund
Journal:  Biochemistry       Date:  2008-06-17       Impact factor: 3.162

3.  Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.

Authors:  Laura Machuca-Tzili; Helena Thorpe; Thelma E Robinson; Caroline Sewry; J David Brook
Journal:  Hum Genet       Date:  2006-08-23       Impact factor: 5.881

4.  Drosophila muscleblind codes for proteins with one and two tandem zinc finger motifs.

Authors:  Uwe Irion
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

5.  Deterministic splicing of Dscam2 is regulated by Muscleblind.

Authors:  Joshua Shing Shun Li; S Sean Millard
Journal:  Sci Adv       Date:  2019-01-16       Impact factor: 14.136

6.  Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells.

Authors:  Kun Huang; Akio Masuda; Guiying Chen; Samira Bushra; Masayoshi Kamon; Toshiyuki Araki; Masanobu Kinoshita; Bisei Ohkawara; Mikako Ito; Kinji Ohno
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

7.  Drosophila muscleblind is involved in troponin T alternative splicing and apoptosis.

Authors:  Marta Vicente-Crespo; Maya Pascual; Juan M Fernandez-Costa; Amparo Garcia-Lopez; Lidón Monferrer; M Eugenia Miranda; Lei Zhou; Ruben D Artero
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

8.  Genetic and chemical modifiers of a CUG toxicity model in Drosophila.

Authors:  Amparo Garcia-Lopez; Lidon Monferrer; Irma Garcia-Alcover; Marta Vicente-Crespo; M Carmen Alvarez-Abril; Ruben D Artero
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

9.  Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.

Authors:  Chun-Ho Wong; Lien Nguyen; Jessie Peh; Long M Luu; Jeannette S Sanchez; Stacie L Richardson; Tiziano Tuccinardi; Ho Tsoi; Wood Yee Chan; H Y Edwin Chan; Anne M Baranger; Paul J Hergenrother; Steven C Zimmerman
Journal:  J Am Chem Soc       Date:  2014-04-22       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.